John Lowe

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo-controlled trial

Colin Powell, Ruwanthi Kolamunnage‐Dona, John Lowe et al. · The Lancet Respiratory Medicine · 2013 · 78 citations

Pharmacy, Pediatrics, Pharmacotherapy +14

Early-term birth is a risk factor for wheezing in childhood: A cross-sectional population study

Martin Edwards, Sarah J. Kotecha, John Lowe et al. · Journal of Allergy and Clinical Immunology · 2015 · 62 citations · Full text

Public Health, Child Health, Pediatrics +14

Management of Prematurity-Associated Wheeze and Its Association with Atopy

Martin Edwards, Sarah J. Kotecha, Sarah J. Kotecha et al. · PLoS ONE · 2016 · 47 citations · Full text

Public Health, Child Health, Pediatrics +17

Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial

John Lowe, David Gillespie, Ali F. Aboklaish et al. · The Lancet Respiratory Medicine · 2024 · 36 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +17